LONDON, May 10 (Reuters) - Vectura Group Plc:
* Announces start of Phase III clinical study with QVA149 by Novartis
* Study triggers $7.5M milestone payment
((London Equities Newsroom; +44 20 7542 7717))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Announces start of Phase III clinical study with QVA149 by Novartis
* Study triggers $7.5M milestone payment
((London Equities Newsroom; +44 20 7542 7717))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.